Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Omega-3-acid ethyl esters therapeutics - Trygg Pharma

Next Previous
Drug Profile

Omega-3-acid ethyl esters therapeutics - Trygg Pharma

Alternative Names: AKR-963; AKR-996; Omtryg

Latest Information Update: 30 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Trygg Pharma
  • Class Antihyperlipidaemics; Omega 3 fatty acids
  • Mechanism of Action Lipid modulators; Triglyceride modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertriglyceridaemia
  • No development reported Myocardial infarction

Most Recent Events

  • 28 Apr 2019 No recent reports of development identified for research development in Myocardial-infarction(Adjunctive treatment, Prevention) in Norway (PO, Capsule)
  • 27 Mar 2015 Early research in Myocardial infarction (Prevention, Adjunctive treatment) in Norway (PO) (Trygg Pharma, pipeline, March 2015)
  • 24 Jun 2014 Launched for Hypertriglyceridaemia (Adjunctive treatment) in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top